Curis, Inc.
Curis, Inc.

Curis, Inc.

hand in laptop pointing to email icon

Your dream job…could be 1 update away

Curis, Inc. Careers, Jobs, and Salary Information

Find High Paying Jobs and Compensation Information at Curis, Inc.

Curis, Inc. is a biotechnology company that develops and commercializes drug candidates for the treatment of cancer. The company's lead product candidate, CUDC-907, is an oral, small molecule inhibitor of HDAC and PI3K enzymes, which is being developed for the treatment of patients with lymphoma and solid tumors. Curis is also developing CA-4948, a small molecule inhibitor of the IRAK4 kinase, for the treatment of patients with hematologic cancers. The company has collaborations with several pharmaceutical companies, including Aurigene, Genentech, and ImmuNext, to develop and commercialize its drug candidates. Curis was founded in 2000 and is headquartered in Lexington, Massachusetts.

Snapshot

Employees47
Market Cap$46.4 million
Revenue$11.1 million
5 Year Trendarrow trend up+7.2%
Net Income-$31 million
NASDAQCRIS
Founded2000
pie chartAnnual Report
stats icon
Total value of jobs:
$900,519
stats icon
Total Jobs:
4
stats icon
Average Pay:
$112,564
stats icon
% Masters:
33%

High-Paying Jobs at Curis, Inc.

View All Jobs blue arrow